US4169152A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Isohexide and tetrahydrofuran ethers and their carbamates in method of bringing about relaxation of skeletal musculature
Assignee: Zeneca Inc
•
Filing: 1977-10-31
•
Granted: 1979-09-25
•
Expires: 1997-10-31
Abstract
Abstract Disclosed are isohexide and tetrahydrofuran ethers and their carbamates and pharmaceutical compositions thereof and related compounds that exhibit central nervous system depressant activity, particularly skeletal muscle relaxant activity.
Inventors
- 👤 John W. LeMaistre
- 👤 Taketoshi P. Mori
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-26 17:58
CPC Classifications
C; C07; C07D; C07D493/00; C07D493/02; C07D493/04; C07D307/00; C07D307/02; C07D307/04; C07D307/18; C07D307/20
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
178 words
A method of bringing about relaxation of skeletal musculature in a mammal comprising administering to a mammal therapeutically effective amount of a compound selected from the group consisting of those represented by the formulas: ##STR28## wherein each R 1 is a radical independently selected from the group consisting of hydrogen, aryl, aralkyl where the aralkyl radical contains from 9 to 12 carbon atoms, alkyl substituted aryl, haloalkyl substituted aryl, alkoxy substituted aryl, halogen substituted aryl, alkyl substituted aralkyl, haloalkyl substituted aralkyl, alkoxy substituted aralkyl, mono-halogen substituted aralkyl where the aralkyl radical contains from 7 to 12 carbon atoms, di- and tri-halogen substituted aralkyl where the aralkyl radical contains from 9 to 12 carbon atoms, and ##STR29## and each R 2 is independently selected from the group consisting of hydrogen, aryl, aralkyl, alkyl substituted aryl, haloalkyl substituted aryl, alkoxy substituted aryl, halogen substituted aryl, alkyl substituted aralkyl, haloalkyl substituted aralkyl, alkoxy substituted aralkyl, halogen substituted aralkyl, and ##STR30## with the proviso that at least one R 1 and R 2 in each formula is other than hydrogen or ##STR31##
Claim 2
Independent Claim
178 words
A method of bringing about relaxation of skeletal musculature in a mammal comprising administering to a mammal therapeutically effective amount of a compound selected from the group consisting of those represented by the formulas: ##STR28## wherein each R 1 is a radical independently selected from the group consisting of hydrogen, aryl, aralkyl where the aralkyl radical contains from 9 to 12 carbon atoms, alkyl substituted aryl, haloalkyl substituted aryl, alkoxy substituted aryl, halogen substituted aryl, alkyl substituted aralkyl, haloalkyl substituted aralkyl, alkoxy substituted aralkyl, mono-halogen substituted aralkyl where the aralkyl radical contains from 7 to 12 carbon atoms, di- and tri-halogen substituted aralkyl where the aralkyl radical contains from 9 to 12 carbon atoms, and ##STR29## and each R 2 is independently selected from the group consisting of hydrogen, aryl, aralkyl, alkyl substituted aryl, haloalkyl substituted aryl, alkoxy substituted aryl, halogen substituted aryl, alkyl substituted aralkyl, haloalkyl substituted aralkyl, alkoxy substituted aralkyl, halogen substituted aralkyl, and ##STR30## with the proviso that at least one R 1 and R 2 in each formula is other than hydrogen or ##STR31##
Claim 3
Independent Claim
206 words
A method of bringing about relaxation of skeletal musculature in a mammal comprising administering to a mammal a therapeutically effective amount of a compound selected from the group consisting of those represented by the formula: ##STR32## wherein each R 1 is a radical independently selected from the group consisting of hydrogen, phenyl, phenylalkyl (C 3 to C 6 ), alkyl (C 1 to C 6 ) substituted phenyl, haloalkyl (C 1 to C 6 ) substituted phenyl, alkoxy (C 1 to C 6 ) substituted phenyl, halogen substituted phenyl, alkyl (C 1 to C 6 ) substituted phenylalkyl (C 1 to C 6 ) where the substitution is on the phenyl ring, haloalkyl (C 1 to C 6 ) substituted phenyl alkyl (C 1 to C 6 ) where the substitution is on the phenyl ring, alkoxy (C 1 to C 6 ) substituted phenylalkyl (C 1 to C 6 ) where the substitution is on the phenyl ring, di- and tri-halogen substituted phenylalkyl (C 3 to C 6 ) where the substitution is on the phenyl ring, mono-halogen substituted benzyl where the substitution is on the phenyl ring, and ##STR33## with the proviso that at least one R 1 is other than hydrogen or ##STR34##
Claim 4
Independent Claim
206 words
A method of bringing about relaxation of skeletal musculature in a mammal comprising administering to a mammal a therapeutically effective amount of a compound selected from the group consisting of those represented by the formula: ##STR32## wherein each R 1 is a radical independently selected from the group consisting of hydrogen, phenyl, phenylalkyl (C 3 to C 6 ), alkyl (C 1 to C 6 ) substituted phenyl, haloalkyl (C 1 to C 6 ) substituted phenyl, alkoxy (C 1 to C 6 ) substituted phenyl, halogen substituted phenyl, alkyl (C 1 to C 6 ) substituted phenylalkyl (C 1 to C 6 ) where the substitution is on the phenyl ring, haloalkyl (C 1 to C 6 ) substituted phenyl alkyl (C 1 to C 6 ) where the substitution is on the phenyl ring, alkoxy (C 1 to C 6 ) substituted phenylalkyl (C 1 to C 6 ) where the substitution is on the phenyl ring, di- and tri-halogen substituted phenylalkyl (C 3 to C 6 ) where the substitution is on the phenyl ring, mono-halogen substituted benzyl where the substitution is on the phenyl ring, and ##STR33## with the proviso that at least one R 1 is other than hydrogen or ##STR34##
Claim 5
Independent Claim
111 words
A method of bringing about relaxation of skeletal musculature in a mammal comprising administering to a mammal a composition comprised of a therapeutically effective amount of a compound selected from the group consisting of those represented by the formulas: ##STR35## wherein each R 3 and R 4 is a radical independently selected from the group consisting of hydrogen, aryl, aralkyl, alkyl substituted aryl, haloalkyl substituted aryl, alkoxy substituted aryl, halogen substituted aryl, alkyl substituted aralkyl, haloalkyl substituted aralkyl, alkoxy substituted aralkyl, halogen substituted aralkyl, and ##STR36## with the proviso that at least one R 3 and R 4 in each formula is other than hydrogen or ##STR37## in a pharmaceutical carrier.
Claim 6
Independent Claim
111 words
A method of bringing about relaxation of skeletal musculature in a mammal comprising administering to a mammal a composition comprised of a therapeutically effective amount of a compound selected from the group consisting of those represented by the formulas: ##STR35## wherein each R 3 and R 4 is a radical independently selected from the group consisting of hydrogen, aryl, aralkyl, alkyl substituted aryl, haloalkyl substituted aryl, alkoxy substituted aryl, halogen substituted aryl, alkyl substituted aralkyl, haloalkyl substituted aralkyl, alkoxy substituted aralkyl, halogen substituted aralkyl, and ##STR36## with the proviso that at least one R 3 and R 4 in each formula is other than hydrogen or ##STR37## in a pharmaceutical carrier.
Claim 7
Dependent Claim
156 words
A method of claim 1 wherein each R 1 is a radical independently selected from the group consisting of hydrogen, phenyl, phenylpropyl, phenylbutyl, mono-alkyl (C 1 to C 4 ) substituted phenyl, mono-haloalkyl (C 1 to C 4 ) substituted phenyl, mono-alkoxy (C 1 to C 4 ) substituted phenyl, mono-halogen substituted phenyl, mono-alkyl (C 1 to C 4 ) substituted phenylalkyl (C 1 to C 4 ) where the substitution is on the phenyl ring, monohaloalkyl (C 1 to C 4 ) substituted phenylalkyl (C 1 to C 4 ) where the substitution is on the phenyl ring, mono-alkoxy (C 1 to C 4 ) substituted phenylalkyl (C 1 to C 4 ) where the substitution is on the phenyl ring, mono-halogen substituted phenylalkyl (C 1 to C 4 ) where the substitution is on the phenyl ring, and ##STR38## with the proviso that at least one R 1 is other than hydrogen or ##STR39##
Claim 8
Dependent Claim
109 words
A method of claim 1 wherein each R 1 is a radical independently selected from the group consisting of hydrogen, phenyl, phenylpropyl, mono-methyl substituted phenyl, mono-trifluoromethyl substituted phenyl, mono-methoxy substituted phenyl, mono-fluoro substituted phenyl, mono-chloro substituted phenyl, mono-methyl substituted benzyl where the substitution is on the phenyl ring, mono-trifluoromethyl substituted benzyl where the substitution is on the phenyl ring, mono-alkoxy substituted benzyl where the substitution is on the phenyl ring, mono-fluoro substituted benzyl where the substitution is on the phenyl ring, mono-chloro substituted benzyl where the substitution is on the phenyl ring, and ##STR40## with the proviso that at least one R 1 is other than hydrogen or ##STR41##
Claim 9
Independent Claim
192 words
A method of bringing about relaxation of skeletal musculature in a mammal comprising administering to a mammal a therapeutically effective amount of a compound selected from the group consisting of those represented by the formula: ##STR42## where each R 2 is a radical independently selected from the group consisting of hydrogen, phenyl, phenylalkyl (C 1 to C 6 ), alkyl (C 1 to C 6 ) substituted phenyl, haloalkyl (C 1 to C 6 ) substituted phenyl, alkoxy (C 1 to C 6 ) substituted phenyl, halogen substituted phenyl, alkyl (C 1 to C 6 ) substituted phenylalkyl (C 1 to C 6 ) where the substitution is on the phenyl ring, haloalkyl (C 1 to C 6 ) substituted phenylalkyl (C 1 to C 6 ) where the substitution is on the phenyl ring, alkoxy (C 1 to C 6 ) substituted phenylalkyl (C 1 to C 6 ) where the substitution is on the phenyl ring, halogen substituted phenylalkyl (C 1 to C 6 ) where the substitution is on the phenyl ring, and ##STR43## with the proviso that at least one R 2 is other than hydrogen or ##STR44##
Claim 10
Independent Claim
192 words
A method of bringing about relaxation of skeletal musculature in a mammal comprising administering to a mammal a therapeutically effective amount of a compound selected from the group consisting of those represented by the formula: ##STR42## where each R 2 is a radical independently selected from the group consisting of hydrogen, phenyl, phenylalkyl (C 1 to C 6 ), alkyl (C 1 to C 6 ) substituted phenyl, haloalkyl (C 1 to C 6 ) substituted phenyl, alkoxy (C 1 to C 6 ) substituted phenyl, halogen substituted phenyl, alkyl (C 1 to C 6 ) substituted phenylalkyl (C 1 to C 6 ) where the substitution is on the phenyl ring, haloalkyl (C 1 to C 6 ) substituted phenylalkyl (C 1 to C 6 ) where the substitution is on the phenyl ring, alkoxy (C 1 to C 6 ) substituted phenylalkyl (C 1 to C 6 ) where the substitution is on the phenyl ring, halogen substituted phenylalkyl (C 1 to C 6 ) where the substitution is on the phenyl ring, and ##STR43## with the proviso that at least one R 2 is other than hydrogen or ##STR44##
Claim 11
Dependent Claim
10 words
A method of claim 1 wherein the compound is 2-O-(o-chlorobenzyl)isosorbide.
Claim 12
Dependent Claim
10 words
A method of claim 1 wherein the compound is 5-O-(o-chlorobenzyl)isosorbide.
References Cited (Backward Citations)
US2234200A
Cited
US2322820A
Cited
US2420519A
Cited
US2322821A
Cited
US2387842A
Cited
US2572566A
Cited
US2771471A
Cited
US3225068A
Cited
US3225067A
Cited
US3272845A
Cited
US3225066A
Cited
US3342680A
Cited
US3671458A
Cited
US3671550A
Cited
US3734929A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1982-09-24 | 1983-03-26 | 1983-09-25 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1986-09-24 | 1987-03-26 | 1987-09-25 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1990-09-24 | 1991-03-26 | 1991-09-25 | $7700.00 | Window Closed / Lapsed |